Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: J Subst Abuse Treat. 2021 Jun 16;131:108537. doi: 10.1016/j.jsat.2021.108537

Table 4.

Adjusted intent-to-treat multilevel models of clinical outcomes by condition

Insomnia Symptoms Sleep Efficiency Cannabis-Related Problems Average Daily Cannabis Use
B 95% CI SE B 95% CI SE B 95% CI SE B 95% CI SE
Intercept (Baseline) 15.51*** 14.00, 17.02 .77 .73*** .67, .79 .03 5.53*** 3.82, 7.29 .89 3.35*** 2.41, 4.29 .48
PTSD diagnosis 3.27* .17, 6.37 1.58 −.10 −.24, .04 .07 −.18 −3.20, 2.85 1.54 .85 −1.03, 2.73 .96
Condition −1.03 −2.99, .93 1.00 .02 −.08, .12 .05 −.68 −2.91, 1.55 1.14 −.96 −2.22, .29 .64
Session −.17 −1.87, 1.54 1.10 .00 −.01, .01 .00 .08 −1.46, 1.62 .79 −.30 −.72, .12 .22
Condition by session 1.12*** .50, 1.74 .32 −.03 −.07, .01 .02 .65* .13, 1.15 .26 .08 −07, .23 .08

Note.

*=

p<.05;

**=

p<.01;

***=

p<.001.

Treatment condition (0=Brief Behavioral Treatment for Insomnia, 1=Waitlist Control).

SE=standard error. Models are adjusted for Baseline posttraumatic stress disorder (PTSD) diagnostic status.